Multiple Sclerosis Journal - October 2017 - 1552

Multiple Sclerosis Journal 23(11)
7. Khan F, Amatya B and Galea M. Management of
fatigue in persons with multiple sclerosis. Front
Neurol 2014; 5: 177.
8. Van Kessel K and Moss-Morris R. Understanding
multiple sclerosis fatigue: A synthesis of biological
and psychological factors. J Psychosom Res 2006;
61(5): 583-585.
9. Knoop H, Bleijenberg G, Gielissen MF, et al. Is a full
recovery possible after cognitive behavioural therapy
for chronic fatigue syndrome? Psychother Psychosom
2007; 76(3): 171-176.
10. Van den Akker LE, Beckerman H, Collette EH,
et al. Effectiveness of cognitive behavioral therapy
for the treatment of fatigue in patients with multiple
sclerosis: A systematic review and meta-analysis. J
Psychosom Res 2016; 90(11): 33-42.
11. Van Kessel K, Moss-Morris R, Willoughby E, et al.
A randomized controlled trial of cognitive behavior
therapy for multiple sclerosis fatigue. Psychosom Med
2008; 70(2): 205-213.
12. Beckerman H, Blikman LJ, Heine M, et al.
The effectiveness of aerobic training, cognitive
behavioural therapy, and energy conservation
management in treating MS-related fatigue: The
design of the TREFAMS-ACE programme. Trials
2013; 12(14): 250.
13. Boutron I, Moher D, Altman DG, et al.; CONSORT
Group. Extending the CONSORT statement to
randomized trials of nonpharmacologic treatment:
Explanation and elaboration. Ann Intern Med 2008;
148(4): 295-309.
14. Vercoulen J, Swanink C, Fennis J, et al. Dimensional
assessment of chronic fatigue syndrome. J Psychosom
Res 1994; 38(5): 383-392.
15. Cardol M, de Haan R, van den Bos G, et al. The
development of a handicap assessment questionnaire:
The Impact on Participation and Autonomy (IPA).
Clin Rehabil 1999; 13(5): 411-419.
16. Krupp LB, LaRocca NG, Muir-Nash J, et al. The
fatigue severity scale. Application to patients with
multiple sclerosis and systemic lupus erythematosus.
Arch Neurol 1989; 46(10): 1121-1123.
17. Kos D, Kerckhofs E, Nagels G, et al. Assessing
fatigue in multiple sclerosis: Dutch modified fatigue
impact scale. Acta Neurol Belg 2003; 103: 185-191.

1552

20. Rietberg MB, Van Wegen EE and Kwakkel G.
Measuring fatigue in patients with multiple sclerosis:
Reproducibility, responsiveness and concurrent
validity of three Dutch self-report questionnaires.
Disabil Rehabil 2010; 32(22): 1870-1876.
21. Cardol M, Beelen A, van den Bos G, et al.
Responsiveness of the Impact on Participation and
Autonomy questionnaire. Arch Phys Med Rehabil
2002; 83(11): 1524-1529.
22. Van der Werf SP, Jongen PJH, Lycklama A, et al.
Fatigue in multiple sclerosis: Interrelations between
fatigue complaints, cerebral MRI abnormalities and
neurological disability. J Neurol Sci 1998; 160:
164-170.
23. Gielissen MF, Verhagen S, Witjes F, et al. Effects of
cognitive behavior therapy in severely fatigued diseasefree cancer patients compared with patients waiting for
cognitive behavior therapy: A randomized controlled
trial. J Clin Oncol 2006; 24(30): 4882-4887.
24. Yu LM, Chan AW, Hopewell S, et al. Reporting on
covariate adjustment in randomised controlled trials
before and after revision of the 2001 CONSORT
statement: A literature review. Trials 2010; 11: 59.
25. Sedgwick P. Measuring the benefit of treatment:
Number needed to treat. BMJ 2015; 350: h2206.
26. Thomas S, Thomas PW, Kersten P, et al. A pragmatic
parallel arm multi-center randomised controlled trial
to assess the effectiveness and cost-effectiveness
of a group-based fatigue management programme
(FACETS) for people with multiple sclerosis. J Neurol
Neurosurg Psychiatry 2013; 8410: 1092-1099.
27. Ehde DM, Elzea JL, Verrall AM, et al. Efficacy of
a telephone-delivered self-management intervention
for persons with multiple sclerosis: A randomized
controlled trial with a one-year follow-up. Arch Phys
Med Rehabil; 2015; 96(11): 1945-1958.
28. Van den Akker LE, Beckerman H, Collette EH,
et al. Effectiveness of cognitive behavioral therapy
for the treatment of fatigue in patients with multiple
sclerosis: A systematic review and meta-analysis. J
Psychosom Res 2016; 90: 33-42.
29. Duquin JA, Parmenter BA and Benedict RH.
Influence of recruitment and participation bias in
neuropsychological research among MS patients. J Int
Neuropsychol Soc 2008; 143: 494-498.

18. Aaronson NK, Muller M, Cohen PD, et al.
Translation, validation, and norming of the Dutch
language version of the SF-36 Health Survey in
community and chronic disease populations. J Clin
Epidemiol 1998; 51(11): 1055-1068.

Appendix 1

19. Van Bennekom CA, Jelles F, Lankhorst GJ, et al. The
Rehabilitation Activities Profile: A validation study
of its use as a disability index with stroke patients.
Arch Phys Med Rehabil 1995; 76(6): 501-507.

TREFAMS-ACE Study Group
V de Groot and H Beckerman (program coordination), A Malekzadeh, LE van den Akker, M Looijmans
(until September 2013), SA Sanches (until February
journals.sagepub.com/home/msj

https://journals.sagepub.com/home/msj

Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017